.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
HAZE is stocked at 98 licensed dispensaries across Florida, New Jersey, and Nevada, 62 of them in Florida, with the deepest coverage in Orlando, Fort Myers, Pensacola, Tampa, and Winter Haven. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, HAZE concentrated 56.85% of sales in Vapor Pens with a month-over-month gain of 17.30% but a year-over-year decline of 34.05%, while Concentrates held 29.42% share with a sharper 40.37% MoM increase against an 83.33% YoY drop. Edible fell to 8.74% share with a 34.01% MoM decrease and a 74.29% YoY decline, and Pre-Roll slid to 4.98% share with a 39.49% MoM drop and a 75.94% YoY contraction. Average price rose 23.35% YoY to $31.91 as Vapor Pens averaged $34.25 and Concentrates $39.07, indicating mix- and price-driven revenue preservation amid a 68.49% YoY brand sales decline; the pattern implies HAZE is leaning into higher-priced inhalables to offset volume erosion in Edible and Pre-Roll.
The mix shift toward Vapor Pens and Concentrates, paired with a YoY average price lift of 23.35% and a Vapor Pens rank of 54 in New Jersey, suggests a positioning anchored in premium-leaning inhalables rather than value-led form factors. With Vapor Pens and Concentrates combining for 86.28% share and posting MoM gains of 17.30% and 40.37% respectively despite steep YoY declines of 34.05% and 83.33%, the near-term trajectory points to tactical recovery via core inhalables while deprioritizing Edible and Pre-Roll, which contracted 34.01% and 39.49% MoM; the implication is that HAZE’s defensible space is depth in inhalables where price elasticity supports margin even as unit velocity softens.
Competitive Landscape
HAZE sits at rank #54 in New Jersey Vapor Pens in August 2026, down 8 positions year over year from #46, yet up 13 spots versus May 2026 when it was #67; by contrast, RYTHM climbed from #7 to #5 while growing sales 14.0%, and Select held #1 but with a 21.2% sales decline year over year. Although HAZE’s current #54 is far from its peak #19 achieved in November 2024, the 3-month improvement of 19.4% in rank (from #67 to #54) coincides with category leaders splitting—one advancing in rank and another contracting in sales—suggesting HAZE’s downward YoY rank trajectory masks near-term momentum that can convert into share capture if the short-run climb continues.
Notable Products
Haze x Mudd Bros - Black Razz Live Resin Gummies 10-Pack (100mg) posted a -23.7% month-over-month drop while sliding to rank 5, making it the steepest decline in August 2026 and signaling softness in Edibles even as Citrus OG Live Rosin Gummies 10-Pack (100mg) in the same category inched up +4.9% at rank 8. At the top, Haze x Mudd Brothers - Snowfall Live Rosin Cartridge (0.5g) held rank 1 with a +2.5% lift, and four of the top ten are Vapor Pens clustered between ranks 1 and 10, indicating the format’s depth is anchoring share despite mixed edible trends. The coexistence of a rank-1 pen gaining modestly and a -23.7% edible contraction points to HAZE leaning into inhalable-led velocity while treating Edibles as a secondary, volatility-prone lane.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
